Home > Animal Health & Nutrition > Veterinary Services > Swine Artificial Insemination Market

Swine Artificial Insemination Market Trends

Report ID: GMI10220
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Swine Artificial Insemination Market Trends

Artificial insemination minimizes the disease risks by eliminating the need for physical interaction between animals during breeding, as traditional natural mating methods can lead to disease transmission through direct contact between animals, posing serious health risks to swine herds.

For instance, as per an article published by the University of Nebraska – Lincoln, the most common infectious causes of reproductive problems in swine are parvovirus, enterovirus, leptospirosis and pseudorabies. Thus, swine producers are increasingly turning to artificial insemination as a safer and more reliable method for breeding, thereby stimulating the demand for artificial insemination services and technologies in the market.

Additionally, governmental and regulatory support for disease control measures encourages the adoption of artificial insemination, reinforcing its role in driving market growth.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global swine artificial insemination market was valued at USD 1.8 billion in 2023 and will grow at 6.5% CAGR during 2024-2032, driven by improved artificial insemination techniques and equipment.

The instruments segment in the market recorded a revenue of USD 724.5 million in 2023 and will grow rapidly through 2032, owing to higher accuracy and efficiency.

North America swine artificial insemination market secured 40.2% substantial share in 2023 and will expand rapidly through 2032, driven by the availability of skilled veterinarians and technical experts.

Hypor B.V, IMV Technologies Group, Magapor S.L, MINITUB GmbH, Neogen Corporation, PIC (Pig Improvement Company), Semen Cardona S.L, Shipley Swine Genetics, and Swine Genetics International among others.